3i Diagnostics has emerged from 'stealth mode' and have presented details of our technology to the public


At the 70th American Association of Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo we were awarded the inaugural "Distinguished Abstract" Award by the History of Clinical Chemistry Division.

AACC award certificate.png

The award recognized our work, from among the thousand or more that were submitted, as having the potential to significantly impact clinical chemistry.  The award was presented during the 2018 Annual meeting of the AACC during the History Division luncheon and included a presentation of the work by founder and CTO Rajesh Krishnamurthy. Independently, the poster was also selected by the Annual Meeting Organizing Committee (one of four chosen for this honor) for an Oral Presentation as part of a discussion on Emerging Biomarkers and Technologies. “This is a significant honor for 3iDx said CEO Jim Janicki. The AACC annual meeting showcases the world’s leading clinical laboratory technology, and we’re very happy to have been selected to present here. This is a great event for us because so many of the attendees really understand the challenges in rapid, universal microbial ID and are enthusiastic about the possibilities of Biospectrix.”